ZSAN News and Press, Zosano Pharma Corporation From 01/05/22

FREMONT, Calif., Jan. 05, 2022 (GLOBE NEWSWIRE) -- In a press release published under the same headline today by Zosano Pharma Corporation (Nasdaq:ZSAN), a measurement was incorrectly stated as grams, not micrograms. The measurements of the vaccine should have been 10μg and 15μ...

FREMONT, Calif., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced the publication of Phase 1 clinical trial data in an article titled, “ Immunogenicity and Safety of Inactivated Influenza Spl...

FREMONT, Calif., Dec. 13, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced changes to its board of directors, including the appointment of Elaine M. Yang. “We are pleased to welcome Elaine, a high...

FREMONT, Calif., Nov. 29, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that the Board of Directors granted a stock option to purchase 220,000 shares of Zosano’s common stock to a new employee as an induc...

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Zosano Pharma Corporation (NASDAQ: ZSAN) Announces the Successful Formulation of a COVID-19 Vaccine Candidate on its Microneedle Patch System ” Zosano Phar...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Today’s hot penny stocks are catching the eyes of investors and we’re diving into everything investors need to know about them on Wednesday! Source: John Brueske/Shutterstock.com Before we get onto the...

Zosano Pharma (NASDAQ:ZSAN) has gained ~12.5% in the pre-market after the company announced the successful formulation of a COVID-19 vaccine candidate using its microneedle patch system. Zosano’s patch, consisting of a range of nearly two thousand drug-coated titanium mi...

FREMONT, Calif., Nov. 17, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced the successful formulation of a COVID-19 vaccine candidate, obtained from a vaccine developer, utilizing Zosano’s microneedle p...

Zosano Pharma  (NASDAQ:ZSAN): Q3 GAAP EPS of -$0.07 beats by $0.01. Revenue of $0.25M beats by $0.02M. Press Release For further details see: Zosano Pharma  EPS beats by $0.01, beats on revenue

FREMONT, Calif., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced financial results for the third quarter ended September 30, 2021, as well as business highlights. “This quarter we made s...